VeriMom¿Es ginsenoside rh4 seguro durante el embarazo?
No harmonised CLP classification, no SCCS or CIR cosmetic safety assessment specific to ginsenoside Rh4 was found and there are no published reproductive/teratology studies for Rh4; therefore hazard is default 0. However, some ginsenosides show estrogen-related or bioactive signaling effects in vitro and Rh4 shows biological activity in cultured cells and animal models (e.g. anti‑tumor, AMPK, gut/liver signaling), so a theoretical mechanistic concern (structural/class similarity to other ginsenosides) is noted (m=1). Topical cosmetic exposure is expected to give negligible systemic absorption for a large polar triterpenoid glycoside, so exposure is scored e=0 for pregnant adults. Sources: PubMed studies on Rh4 activity, ECHA substance info (no harmonised CLP), EWG ingredient entry.
Related ingredients
Frequently asked questions
- ¿Es ginsenoside rh4 seguro durante el embarazo?
- No harmonised CLP classification, no SCCS or CIR cosmetic safety assessment specific to ginsenoside Rh4 was found and there are no published reproductive/teratology studies for Rh4; therefore hazard is default 0. However, some ginsenosides show estrogen-related or bioactive signaling effects in vitro and Rh4 shows biological activity in cultured cells and animal models (e.g. anti‑tumor, AMPK, gut/liver signaling), so a theoretical mechanistic concern (structural/class similarity to other ginsenosides) is noted (m=1). Topical cosmetic exposure is expected to give negligible systemic absorption for a large polar triterpenoid glycoside, so exposure is scored e=0 for pregnant adults. Sources: PubMed studies on Rh4 activity, ECHA substance info (no harmonised CLP), EWG ingredient entry.
- ¿Es ginsenoside rh4 seguro durante la lactancia?
- No data showing Rh4 transfers in breastmilk or causes reproductive/lactation toxicity; no regulatory flags (harmonised CLP / SCCS / CIR). Theoretical mechanistic concern retained (m=1) because ginsenosides as a class have bioactivity in vitro and some other ginsenosides have shown estrogen receptor interactions in studies. Expected topical exposure and transfer to milk is low → e=0 for topical use. Relevant data on whole‑ginseng in LactMed highlights general ginseng concerns but does not provide Rh4‑specific breastfeeding data.
- ¿Es ginsenoside rh4 seguro para la piel del bebé?
- No infant‑specific reproductive or developmental toxicity data for Rh4 and no regulatory reproductive classification were identified, so hazard remains 0. Mechanistic score not increased because there is no infant‑specific mechanistic evidence. Exposure for baby skin is increased by +1 from adult (adult e=0 → baby e=1) because infant skin has higher permeability and surface‑area‑to‑weight; Rh4 is not demonstrated to be non‑absorbable. No data were found showing topical Rh4 causes adverse effects in infants 0–3 y.
- ¿Cómo puntúa VeriMom a ginsenoside rh4?
- VeriMom puntúa ginsenoside rh4 en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a ginsenoside rh4 en el embarazo?
- Consulta nuestra lista de alternativas seguras a ginsenoside rh4 según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.